Trials / Conditions / Breast Cancer With Low to Intermediate HER2 Expression
Breast Cancer With Low to Intermediate HER2 Expression
3 registered clinical trials studyying Breast Cancer With Low to Intermediate HER2 Expression — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Canc NCT07389200 | Hao Xu | — |
| Recruiting | Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506 | Oncoliq US Inc | — |
| Completed | Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence NCT01479244 | Galena Biopharma, Inc. | Phase 3 |